TGFB1 and systemic sclerosis: Exogenous stimulation with known SSc pro-fibrotic mediators TGF-β, PDGF-B, and IL-4 decreased miR-29a expression in skin fibroblasts [61], suggesting downstream involvement of miR-29a in these pathways as well.